Genotype-Guided P2Y12 Inhibitor Therapy in CAD: Essential Innovation or Unnecessary Step?

Cardiology Grand Rounds

Friday, January 24, 2025 at 12:00 PM


Grand Round starts in:

Ross Heart Hospital Auditorium - Columbus, OH
January 24th, 2025
1.00 AMA PRA Category 1 Credit Hours

Description

Liz Mann

Marisol Wences

Dates and Times

Start: 1/24/2025 12:00 PM
End: 1/24/2025 1:00 PM

Objectives

Describe genetic variations that affect P2Y12 metabolism

Discuss current evidence for selecting P2Y12i therapy in CAD based on routine CYP2C19 genotype-testing

Review logistical and clinical considerations for CYP2C19 genotype testing in practice

Speakers

  • Liz Mann, PharmD
    • Genotype-Guided P2Y12 Inhibitor Therapy in CAD: Essential Innovation or Unnecessary Step?
  • Marisol Wences, PharmD
    • Genotype-Guided P2Y12 Inhibitor Therapy in CAD: Essential Innovation or Unnecessary Step?

Location

Ross Heart Hospital Auditorium
452 W 10th Ave
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Jami Jasper
Department:
Phone: (614) 685-4682
Email: Jami.jasper@osumc.edu